The complexity of mitogen-activated protein kinases (MAPKs) made simple, Cellular and Molecular Life Sciences, vol.65, pp.3525-3544, 2008. ,
Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival, The FASEB Journal, vol.22, pp.954-965, 2007. ,
Cross-talk between JNK/SAPK and ERK/MAPK Pathways: sustained activation of JNK blocks ERK activation by mitogenic factors, Journal of Biological Chemistry, vol.278, pp.26715-26721, 2003. ,
The subcellular localization of MEK and ERK-A novel nuclear translocation signal (NTS) paves a way to the nucleus, Molecular and Cellular Endocrinology, vol.314, pp.213-220, 2010. ,
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases, Oncogene, vol.26, pp.3203-3213, 2007. ,
Regulation of MAP kinase signaling modules by scaffold proteins in mammals, Annual Review of Cell and Developmental Biology, vol.19, pp.91-118, 2003. ,
Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation, Physiological reviews, vol.81, pp.807-869, 2001. ,
ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions, Microbiology and molecular biology reviews, vol.68, pp.320-344, 2004. ,
When kinases meet mathematics: the systems biology of MAPK signalling, FEBS Letters, vol.579, pp.1891-1895, 2005. ,
The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation, Biochimica et Biophysica Acta (BBA) -Molecular Cell Research, vol.1813, pp.1619-1633, 2011. ,
MAP kinase signalling pathways in cancer, Oncogene, vol.26, pp.3279-3290, 2007. ,
Signal integration by JNK and p38 MAPK pathways in cancer development, Nature Reviews Cancer, vol.9, pp.537-549, 2009. ,
Therapeutic strategies for inhibiting oncogenic BRAF signaling, Current Opinion in Pharmacology, vol.8, pp.419-426, 2008. ,
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy, Expert Opinion on Therapeutic Targets, vol.16, pp.103-119, 2012. ,
Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise, Expert Opinion on Investigational Drugs, vol.19, pp.875-887, 2010. ,
The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer, Expert Opinion on Investigational Drugs, vol.18, pp.1893-1905, 2009. ,
Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyond, Expert Opinion on Investigational Drugs, vol.19, pp.1205-1216, 2010. ,
Chapter 1 Ras Signaling and Therapies. Advances in Cancer Research, vol.102, pp.1-17, 2009. ,
Resistance to MEK inhibitors: should we cotarget upstream?, Science Signalling, vol.4, p.16, 2011. ,
The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment, Cancer and Metastasis Reviews, vol.29, pp.143-149, 2010. ,
Novel mitogen-activated protein kinase kinase inhibitors, Expert Opinion on Investigational Drugs, vol.20, pp.209-220, 2011. ,
Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis, Expert Opinion on Therapeutic Targets, vol.13, pp.1121-1134, 2009. ,
Targeting the RAF-MEK-ERK pathway in cancer therapy, Cancer Letters, vol.283, pp.125-134, 2009. ,
Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail, Biochemical Pharmacology, vol.80, pp.624-637, 2010. ,
Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway, Biochemical Journal, vol.392, p.249, 2005. ,
Ultrasensitivity in the mitogen-activated protein kinase cascade, Proceedings of the National Academy of Sciences, vol.93, pp.10078-10083, 1996. ,
Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades, European Journal of Biochemistry, vol.267, pp.1583-1588, 2001. ,
Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties, Proceedings of the National Academy of Sciences, vol.97, pp.5818-5823, 2000. ,
Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades, The Journal of Cell Biology, vol.164, pp.353-359, 2004. ,
Competing Docking Interactions can Bring About Bistability in the MAPK Cascade, Biophysical Journal, vol.93, pp.2279-2288, 2007. ,
Bistable MAP kinase activity: a plausible mechanism contributing to maintenance of late long-term potentiation, AJP: Cell Physiology, vol.294, pp.503-515, 2007. ,
The mammalian MAPK/ERK pathway exhibits properties of a negative feedback amplifier, Science Signalling, vol.3, p.90, 2010. ,
Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells, FEBS letters, vol.482, pp.169-174, 2000. ,
Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors, Nature biotechnology, vol.20, pp.370-375, 2002. ,
A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling, Biochemical Journal, vol.373, p.451, 2003. ,
Control of MAPK signalling: from complexity to what really matters, Oncogene, vol.24, pp.5533-5542, 2005. ,
Prediction and validation of the distinct dynamics of transient and sustained ERK activation, Nature Cell Biology, vol.7, pp.365-373, 2005. ,
Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway, BMC Systems Biology, vol.3, p.100, 2009. ,
Inputoutput behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data, Molecular Systems Biology, vol.5, p.239, 2009. ,
Dynamical Systems Model for Combinatorial Cancer Therapy Enhances Oncolytic Adenovirus Efficacy by MEK-Inhibition, PLoS Computational Biology, vol.7, p.1001085, 2011. ,
Modeling mechanistic biological networks: An advanced Boolean approach, Bioinformatics, vol.28, pp.557-563, 2011. ,
Dual specificity phosphatases 10 and 16 are positive regulators of EGFstimulated ERK activity: Indirect regulation of ERK signals by JNK/p38 selective MAPK phosphatases, Cellular Signalling, vol.24, pp.1002-1011, 2012. ,
The Logic of EGFR/ErbB Signaling: Theoretical Properties and Analysis of HighThroughput Data, PLoS Computational Biology, vol.5, p.1000438, 2009. ,
A comprehensive pathway map of epidermal growth factor receptor signaling, Molecular Systems Biology, vol.1, pp.1-17, 2005. ,
Dynamics of p53 and NF-kappaB regulation in response to DNA damage and identification of target proteins suitable for therapeutic intervention, BMC Systems Biology, vol.6, p.125, 2012. ,
, The hallmarks of cancer. Cell, vol.100, pp.57-70, 2000.
Deregulation of Rab and Rab Effector Genes in Bladder Cancer, PLoS One, vol.7, p.39469, 2012. ,
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors, The American journal of pathology, vol.158, 1955. ,
Oncogenic FGFR3 gene fusions in bladder cancer, Human Molecular Genetics, vol.22, issue.4, pp.795-803, 2012. ,
Molecular Pathogenesis and Diagnostics of Bladder Cancer, Annual Review of Pathology: Mechanisms of Disease, vol.4, pp.251-285, 2009. ,
Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target Identification, Journal of Clinical Oncology, vol.24, pp.5552-5564, 2006. ,
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization, Genes Dev, vol.12, pp.2424-2433, 1998. ,
CellDesigner: a process diagram editor for gene-regulatory and biochemical networks, BIOSILICO, vol.1, pp.159-162, 2003. ,
Using process diagrams for the graphical representation of biological networks, Nature Biotechnology, vol.23, pp.961-966, 2005. ,
CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks, Proceedings of the IEEE, vol.96, pp.1254-1265, 2008. ,
Logical modelling of regulatory networks with GINsim 2.3, Biosystems, vol.97, pp.134-139, 2009. ,
Logical Modelling of Gene Regulatory Networks with GINsim, Methods in Molecular Biology, vol.804, pp.463-479, 2012. ,
Regulatory networks seen as asynchronous automata: A logical description, Journal of Theoretical Biology, vol.153, pp.80350-80359, 1991. ,
Dynamical behaviour of biological regulatory networks-I. Biological role of feedback loops and practical use of the concept of the loop-characteristic state, Bulletin of Mathematical Biology, vol.57, pp.247-276, 1995. ,
Qualitative analysis of regulatory graphs: a computational tool based on a discrete formal framework, pp.830-832, 2003. ,
Dynamical analysis of a generic Boolean model for the control of the mammalian cell cycle, Bioinformatics, vol.22, pp.124-131, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00310984
Decision diagrams for the representation and analysis of logical models of genetic networks. Computational Methods in Systems Biology, pp.233-247, 2007. ,
Dynamically consistent reduction of logical regulatory graphs, Theoretical Computer Science, vol.412, pp.2207-2218, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01284743
Dynamical modeling and analysis of large cellular regulatory networks, Chaos, vol.23, p.25114, 2013. ,
On the relation between the logical structure of systems and their ability to generate multiple steady states or sustained oscillations, Springer Series in Synergetics, vol.9, pp.180-193, 1981. ,
Graphic requirements for multistability and attractive cycles in a Boolean dynamical framework, Advances in Applied Mathematics, vol.41, pp.335-350, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00692086
Dynamical roles of biological regulatory circuits, Briefings in Bioinformatics, vol.8, pp.220-225, 2007. ,
The Biology of cancer, 2007. ,
Regulation of stressactivated MAP kinase pathways during cell fate decisions, Nagoya journal of medical science, vol.73, pp.1-14, 2011. ,
Mechanism of TGF-b signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition, Current Opinion in Cell Biology, vol.21, pp.166-176, 2009. ,
MMAC1/ PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells, Oncogene, vol.19, pp.5406-5412, 2000. ,
Signaling Networks That Link Cell Proliferation and Cell Fate, Journal of Biological Chemistry, vol.277, 2002. ,
Understanding urothelial carcinoma through cancer pathways, International Journal of Cancer, vol.119, pp.1513-1518, 2006. ,
Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia, Proceedings of the National Academy of Sciences, vol.101, pp.609-614, 2004. ,
Common and Distinct Elements in Cellular Signaling via EGF and FGF Receptors, Science, vol.306, pp.1506-1507, 2004. ,
C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity, Journal of Biological Chemistry, vol.259, pp.2553-2558, 1984. ,
MAP kinase phosphatase-1, a critical negative regulator of the innate immune response, International journal of clinical and experimental medicine, vol.2, p.48, 2009. ,
Mathematical Modelling of Cell-Fate Decision in Response to Death Receptor Engagement, PLoS Computational Biology, vol.6, p.1000702, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00704979
Sixteen years and counting: The current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias, Human Mutation, vol.33, pp.29-41, 2012. ,
Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes, J Cell Physiol, vol.207, pp.800-808, 2006. ,
Continuous time Boolean modeling for biological signaling: application of Gillespie algorithm, BMC Systems Biology, vol.6, p.116, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00762304
Integrating the MAP kinase signal into the G 1 phase cell cycle machinery, Bioessays, vol.22, pp.818-826, 2000. ,
A network model of early events in epidermal growth factor receptor signaling that accounts for combinatorial complexity, Biosystems, vol.83, pp.136-151, 2006. ,
Internal coarsegraining of molecular systems, Proceedings of the National Academy of Sciences of the United States of America, vol.106, pp.6453-6458, 2009. ,
URL : https://hal.archives-ouvertes.fr/inria-00528330
From reaction models to influence graphs and back: a theorem, Formal Methods in Systems Biology, vol.5054, pp.90-102, 2008. ,
URL : https://hal.archives-ouvertes.fr/inria-00419921
Inhibitors of the HSP90 Molecular Chaperone: Current Status. Advances in Cancer Research, vol.95, pp.323-348, 2006. ,
Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer, Journal of the National Cancer Institute, vol.90, pp.1072-1079, 1998. ,
Role of JNK in tumor development, Cell Cycle, vol.2, pp.199-201, 2003. ,
MAP kinases: from intracellular signals to physiology and disease, Physiology, vol.17, pp.62-67, 2002. ,